Effects of hormone replacement therapy on serum lipids and phospholipids in postmenopausal women

Journal of Obstetrics and Gynaecology

Volumn 19, Issue 2, 1999, Pages 184-189

  Nikolaidou Politis, V ^a   Papapanagiotou, A ^a   Kalofoutis, A ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; ESTROGEN; GESTAGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; LIPID METABOLISM; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0033004672     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.1080/01443619965561     Document Type: Article

References (51)

1. Barrett-Connor E. and Bush T. L. (1991) Estrogen and coronary heart disease in women. Journal of the American Medical Association, 265, 1861-1867.
2. Bartlett G. R. (1959) Phosphorus assay in column chromatography. Journal of Biological Chemistry, 234, 466-468.
3. Blumenfeld Z., Aviram M., Brook G. J. and Brandes J. M. (1983) Changes in lipoproteins and subfractions following ophorectomy and estrogen replacement in peri-menopausal women. Maturitas, 5, 77-83.
4. Brunzell J. D., Sniderman A., Albers J. J. and Kwiteravich P. O. (1984) Apoproteins B and A-I and coronary artery disease in humans. Arteriosclerosis, 4, 79-83.
5. Bush T. L., Barrett-Connor E. Cowan L. D., Criqui M. H., Wallace R. B., Suchindran C. M., Tyroler H. A. and Rifkind B. M. (1987a) Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinic Program Follow-Up Study. Circulation, 75, 1102-1109.
6. Bush T. L., Criqui M. H., Cowan L. D., et al. (1987b) Cardiovascular disease mortality in women. Results from the Lipid Research Clinics Follow-Up Study. In Coronary Heart Disease in Women, edited by E., Eaker B., Packard N., Wenger T. Clarkson and H. A. Tyroler. pp. 106-111. New York, Hayarnaker, Doyma.
7. Cheung M. C., Brown B. G., Wolf A. C. and Albers J. J. (1991) Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. Journal of Lipid Research, 32, 383-394.
8. Colditz G. A., Hankinson S. E., Hunter D. J., Willett W. C., Manson J. E., Stampfer M. J., Hennekens C., Rosner B. and Speizer F.F. (1995) The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. New England Journal of Medicine, 332, 1589-1593.
9. Czarnecka H. and Yokoyama S. (1996) Regulation of cellular cholesterol efflux by lecithin: cholesterol acyltransferase reaction through nonspecific lipid exchange. Journal of Biological Chemistry, 271, 2023-2028.
10. Davidson W. S., Rodriguaza W. V., Lund-Katz S., Johnson W. J., Rothblat G. H. and Phillips M. C. (1995) Effects of acceptor particle size on the effux of cellular free cholesterol. Journal of Biological Chemistry, 270, 17106-17113.
11. Egeland G. M., Kuller L. H., Mathews K. A., Kelsey S. F., Cauley J. and Guzick D. (1990) Hormone replacement therapy and lipoprotein changes during early menopause. Obstetrics and Gynecology, 76, 776-782.
12. Eriksson N., Berglund L., Rudling M., Henriksson P. and Angelin B. (1989) Effects of estrogen on low density lipoprotein metabolism in males. Journal of Clinical Investigation, 84, 802-810.
13. Folch J., Lees M. and Sloane-Stanley G. H. (1957) A simple method for the isolation and purification of total lipides from animal tissues. Journal of Biological Chemistry, 226, 497-509.
14. Fournier N. M., de la Llera Moya, Burkey B. F., Swaney J. B., Paterniti J. Jr, Moatti N., Atger V. and Rothblat G. H. (1996) Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apoA-I trangenic rats. Journal of Lipid Research, 37, 1704-1711.
15. Friedewal of W. T., Levy R. I. and Fredrickson S. (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clinical Chemistry, 18, 499-502.
16. Gambrell R. D. (1995) Progestogens in estrogen-replacement therapy. Clinics in Obstetric and Gynaecology, 38, 890-901.
17. Gevers Leuven J. A. (1994) Sex steroids and lipoprotein metabolism. Pharmacology and Therapeutics, 64, 99-126.
18. Gidez L. I., Miller G. J., Burstein M., Slagle S. and Eder H. A. (1982) Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipation procedure. Journal of Lipid Research, 23, 1206-1223.
19. Grodstein F., Stampfer M., Manson J., Colditz G., Willett W., Rosner B., Speizer F. and Herinekens C. H. (1996) Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. New England Journal of Medicine, 335, 453-461.
20. Haffner S. M., Kushwaha R. S., Foster D. M., Applebaum Bowden D. and Hazzard W. R. (1983) Studies on the metabolic mechanism of reduced density lipoproteins during anabolic steroid therapy. Metabolism, 32, 413-420.
21. Hart D. M., Farish E., Fletcher C. D., Howie C. and Kittchener H. (1984) Ten years postmenopausal hormone replacement therapy-affect on lipoproteins. Maturitas, 5, 271-276.
22. Hirvonen E., Lipasti A., Malkonen M., Karkkainen J., Nuntila J., Timonen H. and Manninen V. (1987) Clinical and lipid metabolic effects of unopposed oestrogen and two oestrogen-progestogen regimens in post-menopausal women. Maturitas, 9, 69-74.
23. Horwitz K. B. and Horwitz L. D. (1982) Canine vascular tissues are targets for androgens, estrogens, progestins and glucocorticoids. Journal of Clinical Investigation, 69, 750-758.
24. Hulley S. B., Rosenman R. H., Bawol R. D. and Brand R. J. (1980) Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. New England Journal of Medicine, 302, 1383-1389.
25. Kalofoutis A., Lekakis J. and Miras C. (1981) Heart mitochondrial and microsomal phospholipids fluctuations induced by chronic exercise in rats. International Journal of Biochemistry, 13, 195-199.
26. Kim C. J., Jang H. C., Cho D. H. and Min Y. K. (1994) Effects of hormone replacement therapy on lipoprotein(a) and lipids in postmenopausal women. Arteriosclerosis and Thrombosis, 14, 275-281.
27. Kwiterovich R. O., Sloan M. R. and Fredrickson D. S. (1970) Glycolipids and other lipid constituents of normal human liver. Journal of Lipid Research, 11, 322-330.
28. Lobo R. A. (1995) Benefits and risk of estrogen replacement therapy. American Journal of Obstetrics and Gynecology, 173, 982-989.
29. Ma P. T. S., Yamamoto T., Goldstein J. L. and Brown M. S. (1986) Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17 alpha etinyl estradiol. Proceedings of the National Acadamy of Sciences of the USA, 83, 792-796.
30. Matthews K. A., Meilahn E., Kuller L. H., Kelsey S. F., Caggiula A. W. and Wing R. P. (1989) Menopause and risk factors for coronary heart disease. New England Journal of Medicine, 321, 641-646.
31. Miller V. T., Muesing R. A., LaRosa J. C., Stoy D. B., Phillips E. A. and Stillman R. J. (1991) Effects of conjugated equine estrogen with and without three different progestogens on lipoproteins, high density lipoprotein subfractions and apolipoprotein A-I. Obstetrics and Gynecology, 77, 235-240.
32. Nakao J., Chang W. C., Murota S. L. and Orimo H. (1981) Estradiol-binding sites in rat aortic smooth muscle-cells in culture. Atherosclerosis, 38, 75-80.
33. 2+)-ATPase of erythoyte membrane. Journal of Biological Chemistry, 256, 395-401.
34. Ottosson V. B., Johansson B. G. and von Schoultz B. (1985) Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: a comparison between progestones and natural progesterone. American Journal of Obstetrics and Gynecology, 151, 746-750.
35. Pagarini-Hill A., Dworsky R. and Krauss R. M. (1996) Hormone replacement therapy, hormone levels and lipoprotein cholesterol concentration in elderly women. American Journal of Obstetrics and Gynecology, 174, 897-902.
36. Pownall H. J. and Gotto A. M. Jr (1992) Human plasma liporpoteins in biology and medicine. In: Structure and Functions of Apolipoproteins, edited by M, Rossenan, pp. 1-32. Boca Raton, FL, CRC Press Inc.
37. Sacks F. M. and Walsh B. W. (1990). The effects of reproductive hormones on serum lipoproteins: unresolved issues in biology and clinical practice. Annals of the New York Academy of Science, 592, 272-285.
38. Sarrel P. M. (1994) Blood flow. In: Treatment of the Postmenopausal woman: Basic and Clinical Aspects, edited by R. A., Lobo pp. 251-262. New York, Raven Press.
39. Sonnendecker W. W. E., Polakov E. S., Benade A. S. and Simchowitz R. N. (1989) Serum lipoprotein effects of conjugated estrogen and a sequential conjugated estrogen-medrogestone regimen in hysterectomized postmenopausal women. American Journal of Obstetrics and Gyneceology, 160, 1128-1134.
40. + stimulated adenosine triphosphate system of brain microsomes. Archives of Biochemistry and Biophysics, 154, 56-67.
41. Stampfer M. G., Colditz G. A., Willett W. C., Manson J. E., Rosner B., Speizer F. E. and Hennekens G. H. (1991) Postmenopausal estrogen therapy and cardiovascular disease. Ten-year Follow-Up from Nurses Health Study. New England Journal of Medicine, 325, 756-762.
42. Stumpf W. E., Sar M. and Aumuller G. (1977) The heart: a target organ for estradiol. Science, 196, 319-321.
43. Tikkanen M. J. (1990) Role of plasma lipoprotein in the pathogenesis of atherosclerotic disease with special reference to sex hormone effects. American Journal of Obstetrics and Gynecology, 163, 269-304.
44. Tikkanen M. J. (1996) Estrogens, progestins and lipid metabolism. Maturitas, 23, supplement S51-S55.
45. Tikkanen N. J., Nikkila E. A. and Vartiainen E. (1978) Natural oestrogen as an effective treatment for type-II hyperlipoproteinemia in postmenopausal women. Lancet, ii, 490-492.
46. 2) and postheparin plasma hepatic lipase activity. Atherosclerosis, 40, 365-369.
47. Tikkanen M. J., Kuusi T., Nikkila E. A. and Sane T. (1985) Very low density lipoprotein triglyceride kinetics during hepatic suppression by estrogen. FEBS Letters, 181, 160-164.
48. Tutor J. C., Paz J. M., Areses J. and Garcia F. (1981) Determination of high-density phospholipids and its possible clinical application in the assessment of cardiovascular disease risk. Biometrica, 12, 65-69.
49. Walsh B. W., Schiff J., Rosner B., Greenberg L., Ravnikar V. and Sacks F. M. (1991) Effects of postmenopausal estrogen replacement on the concentration and metabolism of plasma lipoproteins. New England Journal of Medicine, 325, 1196-1204.
50. Walsh B. W., Li H. and Sacks F. M. (1994) Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism. Journal of Lipid Research, 35, 2083-2089.
51. Yamaguchi Y. (1980) Determination of high-density lipoprotein phospholipids in serum. Clinica Chimica Acta, 26, 1275-1277.